ANELYNE Trademark

Trademark Overview

On Monday, September 21, 2015, a trademark application was filed for ANELYNE with the United States Patent and Trademark Office. The USPTO has given the ANELYNE trademark a serial number of 86762924. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 25, 2017. This trademark is owned by Eli Lilly and Company. The ANELYNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders and cancer
anelyne

General Information

Serial Number86762924
Word MarkANELYNE
Filing DateMonday, September 21, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 25, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and disorders and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 24, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, September 25, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 25, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 24, 2017EXTENSION 1 GRANTED
Tuesday, January 24, 2017EXTENSION 1 FILED
Tuesday, January 24, 2017TEAS EXTENSION RECEIVED
Tuesday, August 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 23, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 7, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 28, 2016ASSIGNED TO LIE
Thursday, April 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 3, 2015NON-FINAL ACTION E-MAILED
Tuesday, November 3, 2015NON-FINAL ACTION WRITTEN
Friday, October 30, 2015ASSIGNED TO EXAMINER
Thursday, September 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 24, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

anelyne disorders cancer diseases autoimmune preparations treatment pharmaceutical